ARCHIVES

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 28 No. 35 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

Network Should Collect Some Environmental Information: Collins

August 9, 1996

Crout Resigns As Director Of FDA Drugs Bureau

July 11, 1980

In Brief: Susan O’Brien to move to UC Irvine Health

November 14, 2014

Congressman Carter To Address ACCC Annual Conference

December 3, 1976

Walter Curran Succeeds Brian Leyland-Jones As Director Of Emory’s Cancer Center

September 25, 2009

IOM Committee Will Probe Duke Scandal Together With Other “Omics” Case Studies

January 7, 2011